The majority of patients presenting to an Emergency Department (ED) with chest pain do not have acute myocardial infarction (MI). In particular, patients who have very low levels of high-sensitivity cardiac troponin (hsTn) at presentation are likely at extremely low risk. The STAT Chest Pain Study is testing the hypothesis that patients who present with very low levels of hsTnI (<5 ng/L, Abbott Architect assay) >2 hours after symptom onset can be safely and quickly discharged after a single troponin measurement.
Background:
The majority of patients presenting to an Emergency Department (ED) with chest pain do not have acute myocardial infarction (MI). In particular, patients who have very low levels of high-sensitivity cardiac troponin (hsTn) at presentation are likely at extremely low risk. The STAT Chest Pain Study is testing the hypothesis that patients who present with very low levels of hsTnI (<5 ng/L, Abbott Architect assay) >2 hours after symptom onset can be safely and quickly discharged after a single troponin measurement.
Here we present data from phase 1 of the study.
Methods: This is a prospective cohort study recruiting all patients aged >18 yrs presenting with symptoms suggestive of possible MI to Royal Perth Hospital ED, using opt-out consent. In phase 1, patients were managed according to the current CSANZ/NHF recommended chest pain pathway.
Results: 1,251 consecutive patients were enrolled; of these 37% (468) were discharged directly from the ED with the remainder being admitted for further assessment. 73% (911) of patients presented >2 hrs from the onset of their symptoms, and of these 701 had an initial hsTnI <5 ng/L, representing 56% of all patients. None of these patients had an index MI or an MI in the following 30 days.
Conclusions: These data suggest that MI can be confidently excluded in >50% of patients presenting to ED with chest pain after a single hsTn measurement, and the vast majority could be safely discharged without further testing. This is being prospectively tested in phase 2 of the study. 
P. Tully
The University of Adelaide, Adelaide, Australia Background: Recent empirical work demonstrates an association between blood pressure variability (BPV) with stroke and cardiovascular events, however, the association remains controversial. The objective of this study was to systematically review the literature and quantify the bidirectional association between intra-individual BPV and cerebral small vessel disease (CSVD).
Methods: A systematic review of electronic databases was performed on MEDLINE, EMBASE and SCOPUS from inception until September 2018. Eligibility criteria: Population, adult humans (over 18 years but with no upper age limit) without sub-acute stroke <4 weeks from primary care, community cohort, electronic database registry, or randomised controlled trial; Exposure, BPV quantified by any metric over any duration; Comparison, low versus high or mean BPV; Outcomes, 1) prevalent or incident CSVD or progression of CSVD, and 2) standardised mean difference in BPV.
Findings: Twenty-six articles were included describing 25 studies (11,481 unique brain scans, mean age 73.1 years, 48.3% female). Systolic BPV was associated with CSVD (12 studies, OR = 1.29; 95% CI 1.18 to 1.41) and there was marginal evidence of heterogeneity between BPV and mean systolic pressure effect sizes (p = 0.05 for comparison, I 2 = 74%). Evidence was sparse for diastolic BPV and risk of CSVD (6 studies, OR = 1.30; 95% CI 1.14 to 1.48). Small but significant differences were evident between CSVD populations systolic BPV (15 studies, Hedge's g = 0.28; 95% CI 0.18 to 0.38) and diastolic BPV (Hedge's g = 0.13; 95% CI 0.08 to 0.19) without heterogeneity between BPV and mean pressure effect sizes.
Interpretation: The association between BPV and CSVD has implications for blood pressure monitoring and management in people with CSVD. Background: Home blood pressure monitoring (HBPM) is becoming ubiquitous to current hypertension diagnosis and management, patients training using evidence-based guideline can help improve the accuracy of their measurements. The aim of this study was to determine the effectiveness of an evidence based, patient-centered education package in improving their HBPM knowledge and technique.
Methods: Eligibility criteria included patients who were currently (or recommended to) performing HBPM, medically stable and not undergoing medication review. The measurement instruments were adapted from published instruments, updated with current recommendations from the Australian Expert Consensus Statement for HBPM. The results from the pre-and post-surveys were then compared to determine the effectiveness of the intervention.
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region of South Australia. Nurses performed better than the patient group in both HBPM and hypertension knowledge in pre-intervention (nurses: mean = 11.63, SD ± 2.72; patients: mean = 9.83, SD ± 3.35) and post-intervention (nurses: mean = 16.13, SD ± 0.64; patients: mean = 15.89, SD ± 1.02) questionnaires. Overall HBPM knowledge improved by a mean of 5.58, SD ± 3.29, 95% CI 4.25-6.91, p ≤ 0.001), similarly hypertension knowledge also improved by a mean of 1.42, SD ± 1.65, 95% CI 0.76-2.09, p ≤ 0.001. Participants were very receptive to the education package, the overall level of satisfaction to the contents and delivery method was 85%.
Conclusions:
The intervention provided a significant statistical improvement on participants' HBPM and hypertension knowledge. Further longitudinal studies and RCT are recommended for further improvement of the education package.
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Factors Associated with Symptomatic Hyponatraemia from Hydrochlorothiazide in Asian Hypertensive Patients
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Background: Hydrochlorothiazide is a cheap and effective antihypertensive agent. However, it may cause serious symptomatic hyponatraemia. Reported risk factors for hyponatraemia from hydrochlorothiazide include obesity or advanced age. Most of these studies have been conducted in Western countries.
Objective: To evaluate risk factors for hyponatraemia from hydrochlorothiazide in Asian hypertensive patients.
Methods: The study period was between 2005 and 2014 conducted at the hypertension clinic, tertiary care center. Eligible patients were divided into two groups: those with and those without hyponatraemia. Patients with hyponatraemia were identified using the ICD-10 code E871. Patients in the non-hyponatraemia group were those who had not had any reported hyponatraemia up until their final visit in December 2014. The ratio of hyponatraemia to non-hyponatraemia patients was 1:2. Clinical data of all patients were retrospectively reviewed. Factors that differed significantly between the two groups were analysed using descriptive statistics and logistic regression analysis.
Results: There were 68 patients admitted due to symptomatic hyponatraemia from hydrochlorothiazide. Four independent factors in the model predictive of the occurrence of symptomatic hyponatraemia were demonstrated. Male gender, high body mass index, and high serum albumin were negatively related with occurrence (adjusted ORs of 0.099, 0.683, and 0.122, respectively). High plasma glucose levels were positively related with occurrence, (adjusted OR of 1.030 (95% CI of 1.009, 1.051).
Conclusion 
